참고문헌
- Asamura H. Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? J Thorac Oncol 2006;1:766-7. https://doi.org/10.1016/S1556-0864(15)30403-2
- Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005;128:1461-7. https://doi.org/10.1378/chest.128.3.1461
- Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70. https://doi.org/10.3109/02841869509127197
- Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-70. https://doi.org/10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G
- Wulf J, Hadinger U, Oppitz U, Olshausen B, Flentje M. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000;57:225-36. https://doi.org/10.1016/S0167-8140(00)00226-7
- Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-55. https://doi.org/10.1378/chest.124.5.1946
- Senan S, Guckemberger M, Ricardi U. Stage I non-small cell lung cancer and oligometastatic disease. In: Pass HI, Ball D, Scagliotti GV, editors. IASLC textbook multidisciplinary approach to thoracic oncology textbook. Aurora, CO: International Association for the study of Lung Cancer; 2014.
-
Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I nonsmall cell lung cancer in patients aged
$\geq$ 75 years: outcomes after stereotactic radiotherapy. Cancer 2010;116:406-14. https://doi.org/10.1002/cncr.24759 - Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-9. https://doi.org/10.1200/JCO.2010.30.0731
- Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012;84:1060-70. https://doi.org/10.1016/j.ijrobp.2012.07.2354
- Hayashi S, Tanaka H, Kajiura Y, Ohno Y, Hoshi H. Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer. Radiat Oncol 2014;9:138. https://doi.org/10.1186/1748-717X-9-138
- McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-smallcell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-5. https://doi.org/10.1016/j.ijrobp.2005.03.073
- Hoyer M, Roed H, Hansen AT, et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;66:S128-S135.
- Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-6. https://doi.org/10.1200/JCO.2008.21.5681
- Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6. https://doi.org/10.1001/jama.2010.261
- Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010;68:72-7. https://doi.org/10.1016/j.lungcan.2009.05.007
- Bral S, Gevaert T, Linthout N, et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial. Int J Radiat Oncol Biol Phys 2011;80:1343-9. https://doi.org/10.1016/j.ijrobp.2010.04.056
- Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I nonsmall- cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-54. https://doi.org/10.1016/S0360-3016(97)00589-0
- Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31. https://doi.org/10.1002/cncr.20539
- Kestin L, Grills I, Guckenberger M, et al. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiother Oncol 2014;110:499-504. https://doi.org/10.1016/j.radonc.2014.02.002
- Zhang J, Yang F, Li B, et al. Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage I non-small-cell lung cancer? A meta-analysis. Int J Radiat Oncol Biol Phys 2011;81:e305-16. https://doi.org/10.1016/j.ijrobp.2011.04.034
- Koshy M, Malik R, Weichselbaum RR, Sher DJ. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2015;91:344-50. https://doi.org/10.1016/j.ijrobp.2014.10.002
- Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-9. https://doi.org/10.1200/JCO.2006.07.5937
- Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-92. https://doi.org/10.1016/j.ijrobp.2007.10.053
- Guckenberger M, Allgauer M, Appold S, et al. Safety and efficacy of stereotactic body radiotherapy for stage 1 nonsmall- cell lung cancer in routine clinical practice: a patternsof- care and outcome analysis. J Thorac Oncol 2013;8:1050-8. https://doi.org/10.1097/JTO.0b013e318293dc45
- Ricardi U, Frezza G, Filippi AR, et al. Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study. Lung Cancer 2014;84:248-53. https://doi.org/10.1016/j.lungcan.2014.02.015
- Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol 2012;13:802-9. https://doi.org/10.1016/S1470-2045(12)70242-5
- Andratschke N, Zimmermann F, Boehm E, et al. Stereotactic radiotherapy of histologically proven inoperable stage I nonsmall cell lung cancer: patterns of failure. Radiother Oncol 2011;101:245-9. https://doi.org/10.1016/j.radonc.2011.06.009
- Nyman J, Hallqvist A, Lund JA, et al. SPACE: a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Proceeding of ESTRO 33; 2014 Apr 4-8; Vienna, Austria.
- Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-23. https://doi.org/10.1016/0003-4975(95)00537-U
- Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol 2014;32:2449-55. https://doi.org/10.1200/JCO.2013.50.8762
- Tsutani Y, Miyata Y, Nakayama H, et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg 2013;146:358-64. https://doi.org/10.1016/j.jtcvs.2013.02.008
- Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-35. https://doi.org/10.1200/JCO.2009.25.0928
- Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2010;140:377-86. https://doi.org/10.1016/j.jtcvs.2009.12.054
- Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity scorematched analysis. Ann Oncol 2013;24:1543-8. https://doi.org/10.1093/annonc/mdt026
- Shirvani SM, Jiang J, Chang JY, et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for earlystage non-small cell lung cancers in the elderly. JAMA Surg 2014;149:1244-53. https://doi.org/10.1001/jamasurg.2014.556
- Mokhles S, Verstegen N, Maat AP, et al. Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer 2015;87:283-9. https://doi.org/10.1016/j.lungcan.2015.01.005
- Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8. https://doi.org/10.1016/j.ijrobp.2009.07.1751
- Lagerwaard FJ, Verstegen NE, Haasbeek CJ, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:348-53. https://doi.org/10.1016/j.ijrobp.2011.06.2003
- Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-smallcell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7. https://doi.org/10.1016/S1470-2045(15)70168-3
- Grills IS, Hope AJ, Guckenberger M, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for earlystage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012;7:1382-93. https://doi.org/10.1097/JTO.0b013e318260e00d
- Ueki N, Matsuo Y, Togashi Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol 2015;10:116-25. https://doi.org/10.1097/JTO.0000000000000359
- Guckenberger M, Kestin LL, Hope AJ, et al. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac Oncol 2012;7:542-51. https://doi.org/10.1097/JTO.0b013e31824165d7
- Stanic S, Paulus R, Timmerman RD, et al. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys 2014;88:1092-9. https://doi.org/10.1016/j.ijrobp.2013.12.050
- Lagerwaard FJ, Aaronson NK, Gundy CM, Haasbeek CJ, Slotman BJ, Senan S. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J Thorac Oncol 2012;7:1148-54. https://doi.org/10.1097/JTO.0b013e318252cfef
- Palma DA, Senan S, Haasbeek CJ, Verbakel WF, Vincent A, Lagerwaard F. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of threedimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys 2011;80:506-13. https://doi.org/10.1016/j.ijrobp.2010.02.032
- Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483-91. https://doi.org/10.1016/j.ijrobp.2006.05.008
- Koenig TR, Munden RF, Erasmus JJ, et al. Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002;178:1383-8. https://doi.org/10.2214/ajr.178.6.1781383
- Huang K, Senthi S, Palma DA, et al. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol 2013;109:51-7. https://doi.org/10.1016/j.radonc.2013.06.047
- Bongers EM, Botticella A, Palma DA, et al. Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs. Radiother Oncol 2013;109:95-9. https://doi.org/10.1016/j.radonc.2013.10.011
피인용 문헌
- Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms vol.7, pp.14, 2015, https://doi.org/10.18632/oncotarget.5992
- Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer vol.9, pp.None, 2015, https://doi.org/10.2147/ott.s124311
- Symptom burden in lung cancer: management updates vol.5, pp.2, 2015, https://doi.org/10.2217/lmt-2016-0001
- Stereotactic body radiation therapy for the treatment of a post-chemotherapy remnant lung mass in extensive-stage small-cell lung cancer: A case report vol.12, pp.2, 2015, https://doi.org/10.3892/etm.2016.3359
- Binary moving-blocker-based scatter correction in cone-beam computed tomography with width-truncated projections: proof of concept vol.62, pp.6, 2015, https://doi.org/10.1088/1361-6560/aa5913
- A surgical case of radiotherapy induced esophageal perforation accompanying pyogenic spondylodiscitis: a case report vol.3, pp.None, 2015, https://doi.org/10.1186/s40792-017-0368-1
- Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol vol.8, pp.2, 2018, https://doi.org/10.1136/bmjopen-2017-018519
- 1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT vol.9, pp.None, 2015, https://doi.org/10.2147/lctt.s166320
- Survival of localized NSCLC patients without active treatment or treated with SBRT vol.57, pp.2, 2015, https://doi.org/10.1080/0284186x.2017.1374558
- Lung density change after SABR: A comparative study between tri-Co-60 magnetic resonance-guided system and linear accelerator vol.13, pp.4, 2015, https://doi.org/10.1371/journal.pone.0195196
- Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors vol.19, pp.3, 2015, https://doi.org/10.1016/j.cllc.2017.11.008
- Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT vol.194, pp.9, 2015, https://doi.org/10.1007/s00066-018-1316-0
- Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer vol.31, pp.5, 2015, https://doi.org/10.1080/08941939.2017.1373877
- Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis vol.53, pp.6, 2015, https://doi.org/10.1183/13993003.01568-2018
- Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients vol.19, pp.4, 2015, https://doi.org/10.3892/ol.2020.11407
- Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR pat vol.60, pp.4, 2015, https://doi.org/10.1080/0284186x.2021.1874617
- Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration vol.6, pp.6, 2015, https://doi.org/10.1016/j.adro.2021.100750
- Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases vol.39, pp.4, 2015, https://doi.org/10.3857/roj.2021.00311